Showing results (511-520 of 786) with videos related to

Sort By:
Pageof 79
In Silico Pharmacology|December 1, 2025
In silico screening of potential FGF2 inhibitors for cancer therapyAnna Senrung
In Silico Pharmacology|December 1, 2025
Inhibitory potential of α-amyrin from Calotropis procera against HIV-1 reverse transcriptase: insights from in silico and in vitro assaysEstari Mamidala, Poornima Munipally
In Silico Pharmacology|December 27, 2024
In silico design and assessment of a multi-epitope peptide vaccine against multidrug-resistant Acinetobacter baumanniiShiv Nandan Sah, Sumit Gupta, Neha Bhardwaj, et al.
In Silico Pharmacology|February 10, 2025
Network pharmacology and in silico approach to study the mechanism of quercetin against breast cancerTejveer Singh, Mahi Rastogi, Kulbhushan Thakur
In Silico Pharmacology|December 18, 2023
Unraveling the therapeutic potential of Senna singueana phytochemicals to attenuate pancreatic cancer using protein-protein interactions, molecular docking, and MD simulationAcharya Balkrishna, Darshita Sharma, Manisha Thapliyal, et al.
In Silico Pharmacology|December 5, 2023
Design and study of bioisosteric analogues of the drug Molnupiravir as potential therapeutics against SARS-COV-2: an in silico approachDonia Ghedira, Abderrazak Aziz El Harran, Houyem Abderrazak
In Silico Pharmacology|February 12, 2024
Identification of the potential phytocompounds from Endostemon viscosus against GAPDH : a computational approachKavi Malar Surendran, Saradha Maran, Thandeeswaran Murugesan
In Silico Pharmacology|January 8, 2024
Elucidating the role of phytocompounds from Brassica oleracea var. italic (Broccoli) on hyperthyroidism: an in-silico approachDerina J Pearlin Daniel, Shruthi Shanmugasundaram, Karunya Sri Chandra Mohan, et al.
In Silico Pharmacology|October 30, 2023
A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitroKuteesa R Bisaso, Jackson K Mukonzo, Ene I Ette
In Silico Pharmacology|August 14, 2023
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studiesSunil Kumar, Iqra Ali, Faheem Abbas, et al.
Pageof 79